Elvanse Adult vs Elvanse: What Changed When the Brands Combined?

Elvanse Adult has been discontinued in the UK, and the separate Elvanse Adult and Elvanse brands have been consolidated into a single product called Elvanse. This means adults with ADHD are now prescribed Elvanse rather than Elvanse Adult, while the active medicine remains lisdexamfetamine dimesylate.

The change was mainly administrative and regulatory rather than a change to the medicine itself. The formulation of Elvanse has not changed, and the single brand is now licensed for people aged 6 years and above, including children, adolescents, and adults.

What Was Elvanse Adult?

Elvanse Adult was the adult-specific presentation of lisdexamfetamine dimesylate in the UK. It was licensed as part of a comprehensive treatment programme for ADHD in adults, with prescribing decisions based on symptom severity, chronicity, risk of misuse or diversion, and response to previous ADHD treatment.

For many years, the UK therefore had two branded presentations:

  • Elvanse: licensed for children and adolescents.

  • Elvanse Adult: licensed for adults.

Although the active ingredient was the same, the products had different licences and different patient information leaflets. This sometimes caused confusion at pharmacies, particularly if a prescription specified one brand but only the other was available.

What Changed?

Takeda consolidated Elvanse Adult and Elvanse into a single brand: Elvanse.

The key changes are:

  • Elvanse Adult is no longer available in the UK.

  • Elvanse is now licensed for patients aged 6 years and above, covering children, adolescents, and adults.

  • Prescribers should prescribe Elvanse for all eligible patients aged 6 years and above.

  • There is no longer a need to prescribe lisdexamfetamine by the separate Elvanse Adult brand.

  • Pharmacies will stock Elvanse only, simplifying supply for patients and healthcare professionals.

  • The formulation of Elvanse has not changed.

The EMC listing for Elvanse Adult 30 mg now identifies the product as discontinued.

Did the Medicine Itself Change?

No. The active ingredient remains lisdexamfetamine dimesylate. The consolidation did not alter the formulation of Elvanse.

This means that, in practical terms:

  • Adults continue to receive lisdexamfetamine.

  • The usual dose and administration instructions remain those set by the prescriber and product information.

  • The change should not mean a different medicine, a different dose, or a loss of effect.

  • Any change in how someone feels after the switch should be discussed with the prescriber or pharmacist rather than assumed to be caused by the brand change.

Why Were There Two Brands?

The two-brand system existed because the products were licensed separately for different age groups.

  • Elvanse was licensed for children and adolescents.

  • Elvanse Adult was licensed for adults.

Because the licences differed, the patient information leaflets also differed. However, NHS guidance noted that Elvanse and Elvanse Adult preparations were identical and interchangeable in clinical terms, even though their licensing and leaflets were different.

This distinction could create practical problems. For example, if a prescription said “Elvanse Adult” but the pharmacy only had “Elvanse”, the prescription might need to be amended before it could be dispensed. Combining the brands removes that avoidable barrier.

What Does the Change Mean for Adults?

If you previously took Elvanse Adult, your prescription may now be changed to Elvanse.

This should mean:

  • The same active ingredient: lisdexamfetamine dimesylate.

  • The same formulation.

  • The same prescribed dose, unless your clinician has separately decided to change it.

  • A simpler prescription and pharmacy supply process.

If your repeat prescription still says “Elvanse Adult”, contact your prescriber or pharmacy. Existing Elvanse Adult stock could still be used while available, but once it is no longer obtainable, prescriptions specifying Elvanse Adult may need to be returned to the prescriber for amendment to Elvanse.

What Does the Change Mean for Children and Young People?

For children and young people, the practical change is also limited. They continue to receive Elvanse, but the single brand is now licensed across the wider age range from 6 years upwards.

The consolidation may make supply simpler because pharmacies only need to stock one branded presentation rather than separate child and adult versions.

As always, children and young people should continue to be monitored for:

  • Growth, weight, and appetite.

  • Blood pressure and pulse.

  • Sleep.

  • Mood and behaviour.

  • Response to treatment.

  • Side effects.

Does This Affect Dosing?

No. The brand consolidation does not change the dose you should take.

Elvanse dosing remains individualised and should be prescribed by a clinician with appropriate ADHD expertise. Do not change your dose because the brand name has changed.

If you previously took, for example, 50 mg of Elvanse Adult, you should not automatically assume you need 50 mg of Elvanse without checking. In practice, the formulation has not changed, but prescriptions and dose changes should always be confirmed with the prescriber or pharmacist.

Does This Affect Generic Lisdexamfetamine?

The change concerns the branded Elvanse range. Generic lisdexamfetamine products may still exist separately, depending on availability and licensing.

A prescription written as lisdexamfetamine rather than a specific brand may give a pharmacy more flexibility to supply an available product, subject to the prescription and local arrangements. However, patients should not ask a pharmacy to switch brands or formulations without checking with the prescriber, especially if there are concerns about formulation, availability, or tolerability.

Why Did the Manufacturer Combine the Brands?

The consolidation appears designed to simplify the product range and supply chain.

Potential benefits include:

  • One brand name for all eligible age groups.

  • Fewer prescription errors or pharmacy dispensing delays.

  • Less confusion around patient information leaflets.

  • A more straightforward supply process.

  • Less need for prescribers to specify “Elvanse Adult” separately.

NHS prescribing guidance states that there is no longer a need to prescribe lisdexamfetamine by brand and that pharmacies will only stock Elvanse.

What Should Patients Do Now?

If your prescription says “Elvanse Adult”

Contact your GP, ADHD clinic, or pharmacy to ask whether the prescription needs updating. If Elvanse Adult is no longer obtainable, the prescription may need to be amended to Elvanse.

If your prescription says “Elvanse”

No action is usually needed. Continue taking your prescribed dose and attend your usual reviews.

If you notice a change after switching

Contact your prescriber or pharmacist if you notice:

  • A different appearance or packaging that concerns you.

  • A change in how well the medicine works.

  • New or worsening side effects.

  • Difficulty obtaining your prescription.

  • Any uncertainty about the dose or instructions.

Do not stop or change the dose on your own.

Does This Change ADHD Treatment?

No. The underlying treatment approach remains the same:

  • ADHD should be diagnosed by an appropriately trained clinician.

  • Medication should be considered as part of a comprehensive treatment plan.

  • Treatment should be individualised.

  • Stimulant medicines require monitoring for effectiveness, side effects, cardiovascular health, and adherence.

  • Adults may be offered lisdexamfetamine or methylphenidate as first-line pharmacological options, depending on clinical circumstances and guidance.

The brand consolidation does not change the clinical principles of safe ADHD prescribing.

FAQs

Is Elvanse Adult still available in the UK?

No. Elvanse Adult has been discontinued in the UK.

Is Elvanse the same as Elvanse Adult?

They contain the same active ingredient, lisdexamfetamine dimesylate, and the formulation of Elvanse has not changed. The difference was previously mainly the licence and patient information leaflet.

Can adults still take Elvanse?

Yes. Elvanse is now licensed for people aged 6 years and above, including adults.

Do I need a new prescription?

Possibly. If your prescription still says “Elvanse Adult”, contact your prescriber or pharmacy. Once Elvanse Adult stock is no longer available, the prescription may need to be amended to Elvanse.

Has the dose changed?

No. The brand consolidation does not change your dose. Any dose change should be made only by your prescriber.

Why did my pharmacy say it could not dispense Elvanse Adult?

Because Elvanse Adult has been discontinued. If your prescription specifies Elvanse Adult, it may need to be changed to Elvanse.

Is generic lisdexamfetamine the same as Elvanse?

Generic lisdexamfetamine contains the same active ingredient, but formulations, packaging, and availability can differ. Do not switch products without checking with your prescriber or pharmacist.

Book an ADHD Assessment

If you are unsure whether your ADHD treatment is still right for you, or if you have questions about Elvanse, lisdexamfetamine, or alternative options, a specialist assessment can help.

Focus Gently offers ADHD assessments that consider symptoms, daily functioning, medication history, side effects, and personal goals. A clear assessment can help you understand your options and make informed decisions about treatment.

Do not let confusion about medication brands or prescriptions delay the support you need.

Book an ADHD Assessment with Focus Gently

Next
Next

Stopping or Pausing Elvanse: Safe Breaks and What to Expect